David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACH
3351
Accendra Health
ACH
$89.2M
| $205K | ﹤0.01% |
50,027
+16,322
| +48% | +$103K |
|
3352
CALL
United Parks & Resorts
PRKS
$1.98B
| $204K | ﹤0.01% |
7,900
-82,700
| -91% | -$2.11M |
|
3353
Mercantile Bank Corp
MBWM
$1.04B
| $203K | ﹤0.01% |
+6,215
| New | +$206K |
|
|
PES
3354
DELISTED
Pioneer Energy Services Corp.
PES
| $203K | ﹤0.01% |
114,754
-123,666
| -52% | -$213K |
|
3355
Cintas
CTAS
$81.9B
| $202K | ﹤0.01% |
+4,000
| New | +$194K |
|
|
HTT
3356
PUT
High Templar Tech Ltd
HTT
$399M
| $202K | ﹤0.01% |
+40,000
| New | +$213K |
|
3357
CALL
LiveRamp
RAMP
$2.29B
| $202K | ﹤0.01% |
+3,700
| New | +$183K |
|
|
AKS
3358
CALL
DELISTED
AK Steel Holding Corp
AKS
| $202K | ﹤0.01% |
73,300
-33,900
| -32% | -$96.1K |
|
3359
Stoneridge
SRI
$205M
| $201K | ﹤0.01% |
6,961
-16,765
| -71% | -$458K |
|
|
ACIA
3360
CALL
DELISTED
Acacia Communications Inc
ACIA
| $201K | ﹤0.01% |
+3,500
| New | +$167K |
|
|
FPRX
3361
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $200K | ﹤0.01% |
14,943
-100
| -0.7% | -$1.14K |
|
|
AGTC
3362
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $199K | ﹤0.01% |
47,573
+21,040
| +79% | +$73.5K |
|
3363
PUT
United Natural Foods
UNFI
$2.88B
| $198K | ﹤0.01% |
15,000
| – | – |
|
3364
James Hardie Industries
JHX
$17.6B
| $193K | ﹤0.01% |
15,015
-6,740
| -31% | -$81.1K |
|
3365
Mitek Systems
MITK
$813M
| $193K | ﹤0.01% |
+15,780
| New | +$177K |
|
3366
Tronox
TROX
$880M
| $190K | ﹤0.01% |
14,438
-21,673
| -60% | -$229K |
|
3367
Genie Energy
GNE
$406M
| $189K | ﹤0.01% |
22,221
+12,210
| +122% | +$102K |
|
|
NFBK
3368
DELISTED
Northfield Bancorp
NFBK
| $189K | ﹤0.01% |
13,588
-7,962
| -37% | -$114K |
|
3369
PUT
Under Armour Class C
UA
$2.15B
| $189K | ﹤0.01% |
10,000
| – | – |
|
3370
CALL
Community Health Systems
CYH
$419M
| $187K | ﹤0.01% |
+50,000
| New | +$205K |
|
3371
PUT
JELD-WEN Holding
JELD
$208M
| $187K | ﹤0.01% |
10,600
| – | – |
|
|
SPTN
3372
DELISTED
SpartanNash
SPTN
| $186K | ﹤0.01% |
+11,739
| New | +$225K |
|
3373
CALL
Century Aluminum
CENX
$4.38B
| $185K | ﹤0.01% |
+20,800
| New | +$180K |
|
3374
Kodak
KODK
$924M
| $184K | ﹤0.01% |
62,061
-104,926
| -63% | -$319K |
|
|
AVEO
3375
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $179K | ﹤0.01% |
21,879
-6,586
| -23% | -$68K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.